Point of Care Testing for Improving Risk- Benefit Ratio of Aspirin and Warfarin

Molecular Cytogenetics - United Kingdom
doi 10.1186/1755-8166-7-s1-i54
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Risk-Benefit Profile of Warfarin Versus Aspirin in Patients With Heart Failure and Sinus Rhythm: A Meta-Analysis

Circulation. Heart failure
MedicineCardiovascular MedicineCardiology
2013English

Correlation of Point-Of-Care International Normalized Ratio to Laboratory International Normalized Ratio in Hemodialysis Patients Taking Warfarin

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2008English

Warfarin Versus Warfarin and Aspirin in Atrial Fibrillation

Neurological Bulletin
2011English

Post-Menopausal Hormone Therapy Improving the Risk Benefit Ratio With Ultra-Low Doses of Estrogen

US Endocrinology
EndocrinologyMetabolismDiabetes
2007English

Point-Of-Care Testing for Sexually Transmitted Infections

Current Opinion in Infectious Diseases
Infectious DiseasesMicrobiology
2013English

Fully Transient Electrochemical Testing Strips for Eco-Friendly Point of Care Testing

RSC Advances
ChemistryChemical Engineering
2020English

Business Models & Business Cases for Point-Of-Care Testing

2016English

Point-Of-Care Testing for Infectious Diseases: Past, Present, and Future

Journal of Clinical Microbiology
Microbiology
2017English

Salivary Sensors in Point-Of-Care Testing

Sensors and Materials
Materials ScienceInstrumentation
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy